Thus, identification of alternative approaches to tackle effects of DUX4-mediated toxicity remains an urgent priority, such as addressing the suppression of PAX7 target genes that characterises FSHD (Banerji et al., 2017; Banerji and Zammit, 2021). This evidence concerns the gene DUX4 and facioscapulohumeral muscular dystrophy.